BOSTON — Hundreds of students at Boston College have walked out of their classes to protest recent instances of racism on campus, including two posters that were defaced to say “Black Lives don’t Matter.” Video footage shows the students filing onto a campus lawn around midday Wednesday and chanting, “Black lives matter.” The group Eradicate...
NYS Entity Status
NYS Filing Date
FEBRUARY 05, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - BOSTON LAWN CARE, INC.
Around the Web
- Boston College students walk out to protest racist incidents
By Associated Press - Wednesday Oct 18, 2017
- Recalling Spygate wreckage, the original NY-Boston scandal
By Mark Cannizzaro - Wednesday Sep 6, 2017
Ten years ago “Spygate’’ consumed the NFL with a news cycle it wished never got started. It wrecked relationships, cost the Patriots draft picks and money, and forever tarnished the reputation of the franchise and its Hall of Fame-bound head coach, Bill Belichick. Eric Mangini, then the Jets coach, blew the whistle on the Patriots...
- Boston Tech Watch: Rethink Robotics, SquadLocker, Semcasting & More
By Jeff Engel - Friday Aug 25, 2017
There was a flurry of tech deals announced this week in Boston, including the acquisitions of Applause, Digital Lumens, and Dragon Innovation, and a $6 million investment in GNS Healthcare. Here are a few more deals you might have missed: —Rethink Robotics raised $18 million from investors, part of a funding round announced last December […]
- The City of Boston’s High-Tech Plan to Tackle Income Inequality
By Susan Crawford - Wednesday Sep 27, 2017
A groundbreaking new project in the city of Boston could give cities powerful tools for fighting systemic racism.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]